| A Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066) (NCT00424775) | Merck Sharp & Dohme LLC | 2007-01-01 |
| XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer (NCT00417079) | Sanofi | 2007-01-01 |
| Phase I of BIBW 2992/BIBF 1120 Combination Therapy in Solid Tumors (NCT00730821) | Boehringer Ingelheim | 2007-01-01 |
| Ritalin: Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patients (NCT00273741) | University Hospital, Grenoble | 2007-01-01 |
| Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer (NCT00420381) | Eli Lilly and Company | 2007-01-01 |
| PF-00477736 Is Being Studied In Advanced Solid Tumors In Combination With Chemotherapy With Gemcitabine (NCT00437203) | Pfizer | 2006-12-01 |
| A Research Study of JNJ-26854165 to Determine the Safety and Dose in Patients With Advanced Stage or Refractory Solid Tumors. (NCT00676910) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2006-11-01 |
| A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors (NCT00528619) | Pfizer | 2006-11-01 |
| A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving Chemotherapy (NCT00386152) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2006-11-01 |
| Comparing a Closing System Without a Needle With Positive Pressure to a Heparin Lock With Positive Pressure (NCT00386451) | University Hospital, Ghent | 2006-11-01 |
| A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine (NCT00390676) | Adherex Technologies, Inc. | 2006-11-01 |
| Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594) (NCT00687011) | Merck Sharp & Dohme LLC | 2006-10-10 |
| Impaired Immunity in Patients With Cancer: Influence of Cancer Stage, Chemotherapy, and Cytomegalovirus Infection (NCT00521287) | Mackay Memorial Hospital | 2006-10-01 |
| A Trial for Patients With Advanced/Recurrent Endometrial Cancer (NCT00377520) | Eli Lilly and Company | 2006-09-01 |
| Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer (NCT00300781) | Puma Biotechnology, Inc. | 2006-08-04 |
| Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma (NCT00630084) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2006-08-01 |
| Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancer (NCT01538537) | Traws Pharma, Inc. | 2006-08-01 |
| Identification of Key Blood Molecular Markers for Immunotherapy (NCT00507702) | Stanford University | 2006-07-06 |
| Collection of Tissue Samples for Cancer Research (NCT00900198) | National Cancer Institute (NCI) | 2006-07-06 |
| The GEOLynch Cohort Study (NCT03303833) | Wageningen University | 2006-07-01 |
| Cancer Markers Associated With Occupational Exposure to Trichloroethylene (NCT00481611) | National Cancer Institute (NCI) | 2006-06-15 |
| Association of Formaldehyde Exposure to Myeloid Leukemia in Workers in Guangdong, China (NCT01338285) | National Cancer Institute (NCI) | 2006-06-10 |
| Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer (NCT01538563) | Traws Pharma, Inc. | 2006-06-01 |
| Pharmacokinetic Study of a Single Dose of AVI-4126 (RESTEN-NG®) in Cerebral Spinal Fluid (NCT00343148) | Sarepta Therapeutics, Inc. | 2006-06-01 |
| Hartmann's Versus Primary Anastomosis in Left-sided Colon Perforation (NCT01233713) | University of Zurich | 2006-05-01 |
| A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol. (NCT00443534) | Pfizer | 2006-05-01 |
| Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer (NCT00327171) | Sanofi | 2006-05-01 |
| Intravenous (IV) Lidocaine for Opioid-refractory Pain (NCT00321347) | San Diego Hospice & Palliative Care | 2006-05-01 |
| A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors. (NCT00400361) | Hoffmann-La Roche | 2006-04-01 |
| Genotoxicity Assessment for Patients Undergoing Radiation Treatment (NCT00167427) | Yuhchyau Chen | 2006-04-01 |
| An Open Label Study of Oral Enzastaurin in Participants With Cancer (NCT00309140) | Eli Lilly and Company | 2006-03-01 |
| Biodistribution Study of CMD-193 in Patients With Advanced Tumours Expressing the Lewis-Y Antigen (NCT00293215) | Ludwig Institute for Cancer Research | 2006-02-01 |
| A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemia (NCT01394991) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2006-01-01 |
| A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors (NCT00264472) | Adherex Technologies, Inc. | 2006-01-01 |
| Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor (NCT00454649) | Pfizer | 2005-12-01 |
| BI 6727 Administered Intravenously Every 3 Weeks in Patients With Solid Tumours (NCT02273388) | Boehringer Ingelheim | 2005-11-04 |
| Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies (NCT00256191) | Cortice Biosciences, Inc. | 2005-11-01 |
| Study Evaluating Intravenous CMD-193 in Subjects With Advanced Malignant Solid Tumors (NCT00257881) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-11-01 |
| Comparing Aerobic to Resistance Training in Recovery From Cancer (NCT00237926) | TriService Nursing Research Program | 2005-11-01 |
| Therapy Study of Automated Protocolized vs. Physician-Directed Non-Protocolized Weaning (NCT00606788) | University of Luebeck | 2005-11-01 |
| Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Tumors (NCT00511849) | Pfizer | 2005-11-01 |
| Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors (NCT00225121) | Pfizer | 2005-10-11 |
| A New Tool for Assessing Fatigue in Individuals With Advanced Cancer (NCT00428675) | University of Alberta | 2005-10-01 |
| A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors. (NCT00493155) | Hoffmann-La Roche | 2005-10-01 |
| Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2) (NCT00398749) | Janssen-Cilag B.V. | 2005-10-01 |
| Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer (NCT00207090) | R-Pharm | 2005-09-01 |
| A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children (NCT00213239) | The Hospital for Sick Children | 2005-09-01 |
| Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors (NCT00599924) | Pfizer | 2005-09-01 |
| A Research Study to Evaluate the Safety of R306465, a Drug in Development for Cancer and to Study the Absorption, Break Down and Elimination in Patients With Advanced Solid Malignancies. (NCT00677001) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-09-01 |
| The Pain Pen for Breakthrough Cancer Pain (NCT00125801) | Erasmus Medical Center | 2005-08-01 |
| Study Evaluating TTI-237 in Advanced Malignant Solid Tumors. (NCT00195325) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-08-01 |
| Effect of BAY 43-9006 (Sorafenib) on Cardiovascular Safety Parameters in Cancer Patients (NCT00259129) | Bayer | 2005-08-01 |
| Kid Cards: Teaching Kids About Medicines (NCT00127543) | Children's Mercy Hospital Kansas City | 2005-08-01 |
| Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients (NCT00473577) | Pharmacyclics LLC. | 2005-08-01 |
| Study of Cetuximab in Combination With Tarceva in Patients With Solid Tumors (NCT00207077) | Eli Lilly and Company | 2005-08-01 |
| A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1a (NCT00117013) | National Cancer Institute (NCI) | 2005-06-28 |
| Study of ADH-1 Given Intravenously to Patients With Solid Tumors (NCT00265057) | Adherex Technologies, Inc. | 2005-06-01 |
| Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia (NCT00264108) | Janssen-Cilag B.V. | 2005-06-01 |
| BIBW 2992 After Administration of Docetaxel in Patients With Advanced Solid Tumors (NCT02171676) | Boehringer Ingelheim | 2005-05-01 |
| Study Evaluating TTI-237 in Advanced Malignant Solid Tumors (NCT00195247) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-05-01 |
| Determination of Carboplatin's Optimal Plasmatic Exposure (NCT00145028) | Institut Claudius Regaud | 2005-05-01 |
| Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer (NCT00124930) | Alberta Health services | 2005-05-01 |
| A Study of R547 in Patients With Advanced Solid Tumors. (NCT00400296) | Hoffmann-La Roche | 2005-05-01 |
| A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together (NCT00618124) | Pfizer | 2005-05-01 |
| Study of TPI 287 in Patients With Advanced Malignancies (NCT00113724) | Cortice Biosciences, Inc. | 2005-05-01 |
| A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma (NCT00102609) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-04-01 |
| Dose Escalation Trial of BIBW 2992 Administration in Combination With Docetaxel in Patients With Advanced Solid Tumors (NCT02171741) | Boehringer Ingelheim | 2005-04-01 |
| Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer (NCT00557206) | Minneapolis Veterans Affairs Medical Center | 2005-04-01 |
| Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors (NCT00106353) | Pfizer | 2005-03-01 |
| An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation (NCT00210587) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-02-01 |
| Preserving or Resecting the Normal Appendix in Patients Undergoing Laparoscopy Surgery for Suspected Appendicitis (NCT06917612) | Herlev Hospital | 2005-01-01 |
| Catheterization to Locate Mesenchymal Tumors in Patients With Tumor-Induced Osteomalacia or Oncogenic Osteomalacia (NCT00099762) | National Institute of Dental and Craniofacial Research (NIDCR) | 2004-12-15 |
| Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer (NCT00102752) | Threshold Pharmaceuticals | 2004-12-01 |
| BIBW 2992 in Patients With Advanced Solid Tumors (NCT02171650) | Boehringer Ingelheim | 2004-12-01 |
| A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer (NCT00147485) | Pfizer | 2004-12-01 |
| Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancer (NCT00100672) | INSYS Therapeutics Inc | 2004-12-01 |
| Mind-Body Program for Cancer Patients (NCT00179387) | Albert Einstein College of Medicine | 2004-12-01 |
| Views of Cancer Patients Regarding Financial Conflicts of Interest (NCT00097682) | National Institutes of Health Clinical Center (CC) | 2004-11-18 |
| BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors (NCT00095459) | National Cancer Institute (NCI) | 2004-11-02 |
| Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumours (NCT02171702) | Boehringer Ingelheim | 2004-11-01 |
| Phase I Trial of Docetaxel With Perifosine (NCT00399087) | AEterna Zentaris | 2004-11-01 |
| Dose Escalation Study of Continuous Once-daily Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors (NCT02171728) | Boehringer Ingelheim | 2004-11-01 |
| Phase I Trial of Paclitaxel With Perifosine (NCT00399126) | AEterna Zentaris | 2004-11-01 |
| Study Evaluating CMD-193 in Advanced Malignant Solid Tumors (NCT00161642) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-11-01 |
| Evaluation of a Video Game for Adolescents and Young Adults With Cancer (NCT00425139) | HopeLab Foundation | 2004-10-01 |
| Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors (NCT00094159) | Sunesis Pharmaceuticals | 2004-10-01 |
| Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies (NCT00207129) | R-Pharm | 2004-10-01 |
| A Phase I/II Open Label Extension Study of BIBF 1120 Administered Orally Once or Twice Daily to Establish Safety, Pharmacokinetics and Efficacy in Patients With Advanced Solid Tumours and Clinical Benefit From Previous Therapy With BIBF 1120 (NCT00715403) | Boehringer Ingelheim | 2004-10-01 |
| Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors (NCT00195260) | Pfizer | 2004-10-01 |
| A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer (NCT00141297) | Pfizer | 2004-09-01 |
| A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers (NCT00516945) | Hospital Authority, Hong Kong | 2004-09-01 |
| Phase I Perifosine and Gemcitabine Study (NCT00398697) | AEterna Zentaris | 2004-08-01 |
| BI 2536 BS in Patients With Advanced Solid Tumours and Repeated Administration in Patients With Clinical Benefit (NCT02211872) | Boehringer Ingelheim | 2004-08-01 |
| Dose Escalation Study of BI 2536 BS in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit (NCT02211859) | Boehringer Ingelheim | 2004-08-01 |
| Integrated Care for Cancer Patients; Developing, Implementing and Testing a Programme to Improve Integrated Care (NCT00135980) | Radboud University Medical Center | 2004-08-01 |
| An Observational Study of Blood Management Techniques in Oncology Surgical Treatment (NCT00264095) | Janssen-Cilag B.V. | 2004-07-01 |
| Phase I (PH I) Mad Refractory Solid Tumor Study (NCT00099606) | Bristol-Myers Squibb | 2004-07-01 |
| AZD5438 in Patients With Advanced Solid Malignancies (NCT00088790) | AstraZeneca | 2004-07-01 |
| Data Collection, Clinical Care and Interventions in CCR, NCI (NCT00923065) | National Cancer Institute (NCI) | 2004-06-10 |
| Aging and Family Outcomes in Supportive Care of Advanced Cancer Patients (NCT00106067) | US Department of Veterans Affairs | 2004-06-01 |